Trinity Biotech PLC (TRIB)
0.641
-0.03
(-3.97%)
USD |
NASDAQ |
Mar 28, 16:00
0.645
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Total Liabilities (Quarterly): 123.79M for Sept. 30, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
Amarin Corp PLC | 199.17M |
DBV Technologies SA | 38.30M |
Cellectis SA | 252.51M |
Akari Therapeutics PLC | 9.428M |
Biodexa Pharmaceuticals PLC | 6.628M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 97.45M |
Shareholders Equity (Quarterly) | -26.34M |
Debt to Equity Ratio | -3.106 |
Current Ratio | 1.642 |
Net Debt Paydown Yield | -53.20% |